112 related articles for article (PubMed ID: 16301261)
1. Inhibition of poly (ADP-ribose) synthetase improves pulmonary arterial endothelium-dependent relaxation after ischemic-reperfusion injury of splanchnic artery in rats.
Nagata H; Horiguchi T; Enzan K; Nishikawa T; Suzuki K
Anesth Analg; 2005 Dec; 101(6):1799-1804. PubMed ID: 16301261
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
Cuzzocrea S; Zingarelli B; Costantino G; Szabó A; Salzman AL; Caputi AP; Szabó C
Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
[TBL] [Abstract][Full Text] [Related]
3. A poly(ADP-ribose) synthetase inhibitor, benzamide protects smooth muscle cells but not endothelium against ischemia/reperfusion injury in isolated guinea-pig heart.
Jakubowski A; Lomnicka M
Acta Biochim Pol; 2007; 54(1):199-204. PubMed ID: 17369883
[TBL] [Abstract][Full Text] [Related]
4. Effects of intestinal ischemia-reperfusion on major conduit arteries.
Koksoy C; Uydes-Dogan BS; Kuzu MA; Aydemir-Koksoy A; Demirpence E; Kesenci M
J Invest Surg; 2000; 13(1):35-43. PubMed ID: 10741950
[TBL] [Abstract][Full Text] [Related]
5. Impairment of endothelial-dependent pulmonary vasorelaxation after mesenteric ischemia/reperfusion.
Fullerton DA; Eisenach JH; Friese RS; Agrafojo J; Sheridan BC; McIntyre RC
Surgery; 1996 Nov; 120(5):879-84. PubMed ID: 8909525
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion.
Mazzon E; Dugo L; De SA; Li JH; Caputi AP; Zhang J; Cuzzocrea S
Shock; 2002 Mar; 17(3):222-7. PubMed ID: 11900342
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: role of poly (adenosine 5'-diphosphoribose) synthase.
Chabot F; Mitchell JA; Quinlan GJ; Evans TW
Br J Pharmacol; 1997 Jun; 121(3):485-90. PubMed ID: 9179390
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion.
Piana RN; Wang SY; Friedman M; Sellke FW
Circulation; 1996 Feb; 93(3):544-51. PubMed ID: 8565174
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion.
Di Paola R; Genovese T; Caputi AP; Threadgill M; Thiemermann C; Cuzzocrea S
Eur J Pharmacol; 2004 May; 492(2-3):203-10. PubMed ID: 15178366
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo.
Chatterjee PK; Zacharowski K; Cuzzocrea S; Otto M; Thiemermann C
FASEB J; 2000 Apr; 14(5):641-51. PubMed ID: 10744621
[TBL] [Abstract][Full Text] [Related]
11. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase.
Zingarelli B; Cuzzocrea S; Zsengellér Z; Salzman AL; Szabó C
Cardiovasc Res; 1997 Nov; 36(2):205-15. PubMed ID: 9463632
[TBL] [Abstract][Full Text] [Related]
12. Enhanced prostanoid-mediated vasorelaxation in pulmonary arteries isolated during experimental endotoxemia.
Myers TP; Myers PR; Adams HR; Parker JL
Shock; 1999 Jun; 11(6):436-42. PubMed ID: 10454834
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation.
Pulido EJ; Shames BD; Selzman CH; Barton HA; Banerjee A; Bensard DD; McIntyre RC
Am J Physiol; 1999 Oct; 277(4):L769-76. PubMed ID: 10516218
[TBL] [Abstract][Full Text] [Related]
14. Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase.
Liaudet L; Yang Z; Al-Affar EB; Szabó C
Mol Med; 2001 Jun; 7(6):406-17. PubMed ID: 11474134
[TBL] [Abstract][Full Text] [Related]
15. Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase.
Mazzon E; De Sarro A; Caputi AP; Cuzzocrea S
Shock; 2002 Nov; 18(5):434-9. PubMed ID: 12412622
[TBL] [Abstract][Full Text] [Related]
16. Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia.
Liaudet L; Szabó A; Soriano FG; Zingarelli B; Szabó C; Salzman AL
Shock; 2000 Aug; 14(2):134-41. PubMed ID: 10947156
[TBL] [Abstract][Full Text] [Related]
17. INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.
Szabó G; Soós P; Mandera S; Heger U; Flechtenmacher C; Bährle S; Seres L; Cziráki A; Gries A; Zsengellér Z; Vahl CF; Hagl S; Szabó C
Shock; 2004 May; 21(5):426-32. PubMed ID: 15087818
[TBL] [Abstract][Full Text] [Related]
18. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
[TBL] [Abstract][Full Text] [Related]
19. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary vascular dysfunction induced by high tidal volume mechanical ventilation.
Menendez C; Martinez-Caro L; Moreno L; Nin N; Moral-Sanz J; Morales D; Cogolludo A; Esteban A; Lorente JA; Perez-Vizcaino F
Crit Care Med; 2013 Aug; 41(8):e149-55. PubMed ID: 23514752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
